2nd RNA-Based Therapeutics and Vaccines South Korea Grand Hyatt Incheon, Incheon

South Korea’s mRNA ecosystem is rapidly advancing, fueled by progress from companies like GC Biopharma and EyeGene in clinical-stage vaccines. Also, with the growing momentum of ARPA-H initiatives focused on personalized mRNA cancer therapies and strong government backing continues to drive the development of safer, more effective RNA-based medicines.

Amid this innovation, the World RNA-Based Therapeutics and Vaccines Summit returns to South Korea for its second year, highlighting breakthroughs in mRNA design, therapeutic pipelines, targeted delivery, and solutions to key manufacturing and analytical challenges. This is your chance to de-risk your program strategies, unlock insights from international leaders, and forge networks to develop better RNA medicines for patients faster.

As part of the World Advanced Therapeutics Summit South Korea organized by Hanson Wade, this event offers a platform for cross-learning and connections with experts working in cell and gene therapies and together establish South Korea as a global hub for advanced biopharma innovation.